Andrew Scott Blank
CIK 1789894 · last filed 2026-07-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$497.1K
Companies
2
Total Filings
19
Lifetime Open-Market Net
$1.06M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BCDA | Director | 636,058 | $0.78 | $497.1K | $760.0K | 7 | 2026-07-07 |
| BioCardia, Inc. (BCDAW) Delisted | Director | 503,063 | $0.01 | $3.1K | $300.0K | 12 | 2023-10-19 |
Recent Filings · Page 2 of 2
19 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-09-30 | BioCardia, Inc. (BCDAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-15 | BioCardia, Inc. (BCDAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-04-07 | BioCardia, Inc. (BCDAW) Delisted | Grant (A) | +4,752 | $0 | EDGAR |
| 2021-01-05 | BioCardia, Inc. (BCDAW) Delisted | Grant (A) | +7,643 | $0 | EDGAR |
| 2020-10-09 | BioCardia, Inc. (BCDAW) Delisted | Grant (A) | +4,843 | $0 | EDGAR |
| 2020-07-01 | BioCardia, Inc. (BCDAW) Delisted | Grant (A) | +3,281 | $0 | EDGAR |
| 2020-06-23 | BioCardia, Inc. (BCDAW) Delisted | Buy (P) | +142,850 | $300.0K | EDGAR |
| 2020-05-20 | BioCardia, Inc. (BCDAW) Delisted | Grant (A) | +4,100 | $0 | EDGAR |
| 2020-05-04 | BioCardia, Inc. (BCDAW) Delisted | Grant (A) | +5,906 | $0 | EDGAR |
Showing 11–19 of 19
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.